Market Experts' Stock Recommendations: Buy, Sell or Hold Today?

Gaurav Sharma, head of research at Globe Capital recommended a Hold for the stock. Sustaining above Rs 2,400 would be the first trigger. Thereafter, the stock is going to rise till Rs 2,600-odd levels, and further towards Rs 2,700 levels.

Realty stocks may positive on expectations of an interest rate cut by the RBI at the policy meeting on June 6th are positively influencing the real estate sector and Mumbai property stamp duty collection hits May record high led by luxury sales, Reliance Securities said.

Maintain 'outperform' and raise target price to Rs 10,149 from Rs 9,473. The brokerage expects domestic two-wheeler growth of 5%-6% and export growth of 15%-20% in fiscal 2026.

Avinash Gorakshakar, director of research at Profitmart Securities recommended a Hold for the stock. It is one of the most value-added companies. The next two quarters will hopefully be good and the stock could be re-rated.

Mahesh Ojha of Hensex Securities Pvt recommended a 'Hold' for the stock. If someone is holding for a one-year perspective, the stock could reach Rs 4,200-4,400 levels easily.

Invest4edu Head Aditya Agarwala recommended a 'Buy' target for the stock. The target price is Rs 980 apiece, which implied a 10.2% upside from Friday's close price. The stop loss for the stock is Rs 845 apiece.

Out of 19 analysts tracking the company, nine maintain a 'buy' rating, seven recommend a 'hold,' and three suggest 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 5.8%.

Invest4edu Head Aditya Agarwala recommended a 'Buy' for Indian Bank Ltd. The target price for the stock is Rs 665 apiece, which implied 8.3% upside from Friday's close price. The stop loss for the stock is Rs 590 apiece.

Out of 12 analysts tracking the company, 11 maintain a 'buy' rating, one recommend a 'hold', according to Bloomberg data. The average 12-month consensus price target implies an upside of 10.3%.

IDBI Capital Technical and Derivative Research Head Brijesh Ali suggested a 'Buy' for the stock. The target price for the stock is Rs 2,416, which implied a 8.1% upside from Friday's close price. The stop loss is at Rs 2,179.

Out of 20 analysts tracking the company, 16 maintain a 'buy' rating, one recommends a 'hold,' and one suggests to 'sell', according to Bloomberg data. The average 12-month consensus price target implies an upside of 24.9%

Mahesh Ojha of Hensex Securities Pvt. suggested to book profit on this stock. There's no more triggers on sight for further upside. Fourth-quarter earnings were not that great. According to Ojha, one can book 50% profit at current price level range.

Apollo Hospitals Enterprise Ltd., AstraZeneca Pharma Ltd., Infosys Ltd., and Vodafone Idea Ltd. shares will likely be in focus because of the news flow and fourth-quarter earnings.